Follow this innovation
[ via 
] [?]
Treatment to protect and / or recover sexual function of the cavernosal nerve (sexual potency) after radical prostatectomy
University of California System: University of California, Irvine
posted on 01/27/2012
It is estimated that 1 in 6 men will be diagnosed with prostate cancer in their lifetime. One of the consequences of removing the prostate for prostate cancer is a non-permanent injury of the cavernosal nerve during open radical prostatectomy (RP) or robot-assisted radical prostatectomy (RARP), which may result in post-operative sexual dysfunction. These sexual side effects can severely affect the quality of life for men and their loved ones. Researchers at the University of California, Irvine have developed a new use for an existing compound that can be used to prevent, mitigate, or treat erectile dysfunction associated with prostate removal surgery.
Suggested Uses
The compound may be used to treat erectile dysfunction in men who have undergone prostatectomy due to prostate cancer.
| Copyright: | ©2012, The Regents of the University of California |
|---|
This innovation currently is not available for online licensing. Please contact the case manager at University of California System: University of California, Irvine for more information.
request more info
ProfileFind more innovations
